You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 9, September 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Research Letters
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Dermatologic Disorders, Other
 •Dermatology, Other
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Novel Missense Mutation in the CYLD Gene in a Spanish Family With Multiple Familial Trichoepithelioma

Agustín España, MD; Fermin García-Amigot, PhD; Leyre Aguado, MD; Jesús García-Foncillas, MD

Arch Dermatol. 2007;143(9):1209-1210.

Brooke-Spiegler syndrome (BSS) includes the combination of spiradenomas, cylindromas, and trichoepitheliomas. It has been postulated that BSS results from defects in the regulation of putative stem cells of the folliculosebaceous-apocrine unit.1 This follicular dysregulation may give rise to 3 different genodermatoses: familial cylindromatosis (FC), multiple familial trichoepithelioma (MFT), or the classic triad of BSS.

The gene for FC was mapped to chromosome 16q12-q13.2 At present, 32 different germline mutations in the CYLD gene have been described,3 20 in families with FC, 8 in families with MFT, and 4 in families with BSS. Taken together, these observations suggest that these inherited syndromes associated with skin appendage tumors not only share a common genetic basis but also may represent phenotypic variation of the same disease.4

Report of a Case

An 8-year-old girl came to our department with her parents. Her mother, grandmother, and 2 aunts were diagnosed as having trichoepithelioma since childhood (Figure 1). The parents of our patient wanted to know if their daughter might harbor any genetic susceptibility for these cutaneous lesions.


Figure 1
View larger version (65K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Clinical picture (A) and family pedigree (B) for the present case. A, Multiple trichoepitheliomas are present on the upper eyelids, nose, nasolabial folds, and the upper lip in the mother of the proband. B, Pedigree of the family: for individuals whose DNA samples have been analyzed, the allele sequences at codon 896 have been indicated as G (glycine) or A (alanine). The proband (arrow) encodes for a G on both alleles (G/G), whereas the affected family members are heterozygous for the mutation (black circles) encode an A on the mutant allele.


Blood samples were obtained from available family members and 110 unrelated controls. Genomic DNA was extracted; all coding exons were amplified by polymerase chain reaction; and further sequencing analysis was performed. We identified 1 mutation not previously reported. The mutation was found in all patients but not in the healthy members of this family. The change was a point mutation in exon 20 (G2687C) that resulted in substitution of glycine at 896 by alanine (Figure 2). The mutation was not detected in 110 unrelated controls.


Figure 2
View larger version (43K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Genetic analysis of the family with multiple familial trichoepithelioma. Shown are wild-type DNA (A) and mutant sequences (B) of exon 20 of CYLD from control and affected members, respectively.



Comment

Herein, we report a novel CYLD gene mutation at nucleotide 2687 that carries out 1 amino acid change at glycine 896 in the 4 affected members of this family but not in the proband. The fact that we have not detected this change in 110 unaffected controls makes a contribution to the genotype-phenotype correlation in MFT.

The CYLD gene is considered a negative regulator of nuclear factor kappa B(NF-{kappa}B).5 Thereby, inhibition or inactivation of CYLD enhances the action of NF-kB and leads to increased resistance to apoptosis and carcinogenesis.6

To our knowledge, this mutation has not been previously described. The known mutations of the CYLD gene are mostly located in the C-terminal portion.

Germline mutations display tissue-specific function loss. Another possibility would be that the germline mutation determines the tissues where the preferred second hit occurs. When the second hit occurs in eccrine-apocrine cells, the patients become susceptible to multiple cylindromas; in hair follicle cells, the patients exhibit susceptibility to multiple cylindromas or MFT.6

Our study shows the importance of mutation screening of the CYLD gene in patients affected with FC and MFT as well as their relatives to identify early clinical manifestations. Analysis of control volunteers in this report confirms the role of this missense mutation as the cause of this syndrome. Further studies evaluating the effect of this mutation in animal models must be considered.


AUTHOR INFORMATION

Correspondence: Dr España, Department of Dermatology, University Clinic of Navarra, University of Navarra, PO Box 31080, Pamplona, Navarra, Spain (aespana{at}unav.es).

Financial Disclosure: None reported.

Funding/Support: This study was supported in part by the Spanish Academy of Dermatology.

Role of the Sponsor: The sponsor had no role in the design and conduct of the study, in the collection, analysis and interpretation of data, or in the preparation review, or approval of the manuscript.


REFERENCES

1. Clarke J, Ioffreda M, Helm KF. Multiple trichoepithelioma: a folliculosebaceous-apocrine genodermatosis. Am J Dermatopathol. 2002;24(5):402-405. FULL TEXT | ISI | PUBMED
2. Fenske C, Banerjee P, Holden C, Carter N. Brooke-Spiegler syndrome locus assigned to 16q12-q13. J Invest Dermatol. 2000;114(5):1057-1058. FULL TEXT | ISI | PUBMED
3. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff [registration required]. http://www.hgmd.cf.ac.uk/ac/all/php?gene=CYLD. Accessed February 9, 2007.
4. Bowen S, Gill M, Lee DA; et al. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple trichoepithelioma: lack of genotype-phenotype correlation. J Invest Dermatol. 2005;124(5):919-920. FULL TEXT | ISI | PUBMED
5. Regamey A, Hohl D, Liu JW; et al. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kB activation by tumor necrosis factor. J Exp Med. 2003;198(12):1959-1964. FREE FULL TEXT
6. Liang YH, Gao M, Sun LD; et al. Two novel CYLD gene mutations in Chinese families with trichoepithelioma and a literature review of 16 families with trichoepithelioma reported in China. Br J Dermatol. 2005;153(6):1213-1215. FULL TEXT | ISI | PUBMED


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Clinical, Biochemical, and Genetic Study of 11 Patients With Erythropoietic Protoporphyria Including One With Homozygous Disease
Carmen Herrero, Jordi To-Figueras, Celia Badenas, Manuel Méndez, Patricia Serrano, Rafael Enríquez-Salamanca, and Mario Lecha
Arch Dermatol. 2007;143(9):1125-1129.
ABSTRACT | FULL TEXT  

Familial Acanthosis Nigricans Due to K650T FGFR3 Mutation
David R. Berk, Elaine B. Spector, and Susan J. Bayliss
Arch Dermatol. 2007;143(9):1153-1156.
ABSTRACT | FULL TEXT  

Dermatology and the Human Genome: An Epidemiologic Approach
Marta Gwinn and Muin J. Khoury
Arch Dermatol. 2007;143(9):1194-1196.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CYLD mutations in familial skin appendage tumours
Saggar et al.
J. Med. Genet. 2008;45:298-302.
ABSTRACT | FULL TEXT  

Dermatology and the Human Genome: An Epidemiologic Approach
Gwinn and Khoury
Arch Dermatol 2007;143:1194-1196.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.